Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Files Counterclaims against Carestream

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today filed counterclaims against Carestream Health and denied allegations Carestream made in a recent patent infringement suit it filed against Caliper.

Last month, Rochester, NY-based Carestream alleged in a suit that Caliper is infringing US Patent No. 7,734,325, titled, "Apparatus and Method for Multi-Modal Imaging," which was issued to the firm on June 8, 2010. Specifically, Carestream said that Caliper's IVIS Lumina XR Imaging System uses technology covered by the '325 patent.

Caliper today filed its answer to that complaint, denying all allegations that it is infringing the patent and that Carestream is due any damages. In addition, Caliper has asked the court to declare that it is not infringing the patent, that certain claims in the patent are invalid, and that Caliper is entitled to a judgment that those claims are invalid or unenforceable.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.